Synklino

Synklino

Strives to provide rapid relief and improve long-term survival for transplant recipients by providing fast and safe eradication of cytomegalovirus (CMV) infections. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€119—179m (Dealroom.co estimates Jun 2022.)
Company register number 38778676
Copenhagen Capital Region of Denmark (HQ)
Authorizing premium user...